How much funding has Sharp raised?

Sharp has raised $80.8M in total funding, most recently a Private Equity round.

Who are Sharp's investors?

Sharp's investors include Clayton, Dubilier & Rice.

Where is Sharp headquartered?

Sharp is headquartered in Allentown, Pennsylvania, United States.

What industry is Sharp in?

Sharp operates in Biotech, Healthcare.

Sharp

Acquired

Allentown, United States · $80.8M raised

Biotech

Healthcare

Headquarters: Allentown, Pennsylvania
Employees: 1001–5000
Business Model: B2B
Website: sharpservices.com

Total Funding: $80.8M
Last Round: $80.8M Private Equity
Rounds: 1

About

Sharp is a pharmaceutical CDMO (contract development and manufacturing organization) with more than 70 years of experience, delivering commercial packaging, clinical trial supply services, and small-scale sterile manufacturing. The company partners with pharmaceutical and biopharmaceutical clients from phase I trials through commercial launch and lifecycle management, operating GMP facilities across the US, UK, and EU. Sharp was acquired by UDG Healthcare in 2008 and later acquired from UDG Healthcare by CD&R in 2021.

Summary

Sharp is a Biotech company based in Allentown, United States. It has raised $80.8M in total across 1 round. Investors include Clayton, Dubilier & Rice.